Errol Taylor is a partner in Milbank’s Litigation & Arbitration Group and he leads the firm’s biopharma patent litigation practice. He represents research pharmaceutical, biotechnology and chemical companies in patent litigation and related counseling. He has particular expertise in cases involving generic drug approvals and the Hatch-Waxman Act. Mr. Taylor has served as lead trial counsel in numerous multi-party, multinational cases involving some of the world’s most prescribed medicines.
Education: JD, New York Law School; BA, State University of New York at Oswego